Radany, PhD, is the Chief Executive Officer of AssayQuant Technologies Inc. and a Managing Director at Kensho Partners, roles they have held since 2024 and 2020 respectively. They previously founded NeoGenex and served as CEO/CSO from 1992 to 2002, developing an infectious disease viral diagnostic panel and implementing a high-throughput antiviral screening platform, which was acquired by Diagnostic Hybrids. From 2008 to 2018, they were CEO/President of Verdezyne, a synthetic biology company developing organisms for the sustainable production of chemical intermediates for bioplastics and nylons. They earned a B.Sc. from Colorado State University in 1974 and a Ph.D. from the University of Wyoming in 1979.
This person is not in the org chart
This person is not in any teams
This person is not in any offices